Every year, thousands of people would be willing to join a clinical trial. They have the condition under study, the motivation, and an interest in contributing to progress. Most of them are never given the chance. Geography, lack of awareness, or processes too complex to navigate make them invisible to research, and research is poorer for it.
The problem is not a lack of interest. It is a lack of access. Some patients live too far from research sites. Others cannot afford to take time off work or arrange travel. Many simply never hear about the opportunities available to them. These hidden gaps in the system prevent our research from reflecting the full diversity of real-world patients. The gaps also slow progress, because trials take longer to enroll and sometimes fail altogether.
Solving this issue requires a shift in how we approach recruitment and design. We must build trials that meet patients where they are, not expect patients to overcome complex systems just to be seen. One part of that shift involves expanding clinical trial accessibility. We need to make it easier for people to find, understand, and join research opportunities in ways that work with their lives.
Clinical Trial Accessibility Starts with Awareness
A major reason people remain invisible is that they never hear about clinical trials in the first place. Many do not know that a study might be relevant to them. They may believe trials are only for people in big cities or for those already at major hospitals. This misconception keeps many willing volunteers out of the loop.
Improving awareness means starting in the right places. Community partnerships with local organizations, advocacy groups, and patient influencers can create trusted entry points that connect these patients to opportunities.Working together, we can provide information through channels that people already use and trust.
Language and literacy also matter. Trial listings and recruitment materials often use technical or formal language that feels distant and confusing. Instead, we should ensure communications are written clearly and shared in a variety of formats so patients feel informed and empowered to take the next step.
Online search tools are improving, but there is still work for us to do to boost clinical trial accessibility. Many patients struggle to navigate existing registries or cannot find trials that match their condition. Simplified discovery tools, using plain language, multiple languages, and intuitive interfaces, reduce friction and help patients find trials that are relevant to them.
Rethinking Clinical Trial Recruitment with Communities in Mind
The process of enrolling in a trial can feel overwhelming from the patient’s point of view. From long screening questionnaires to multiple site visits, each step adds another barrier for patients who are already stretched thin. Making this process simpler is one of the most effective ways we can improve clinical trial recruitment.
Clinical trial recruitment strategies should not rely solely on digital ads or hospital databases. Instead, engaging directly with communities helps to uncover untapped interest. Local events, faith-based outreach, and partnerships with cultural leaders can open doors that traditional outreach may miss.
Another approach is to use local ambassadors: individuals from within the community who can share information and answer questions in a personal way. People are more likely to trust someone who understands their background and speaks their language.
Trust also depends on transparency. Patients need to know what participation involves, how their data will be used, and how their voice will be respected. By offering this clarity early in the recruitment process, we can create an environment where patients feel safe and supported.
Hybrid Trial Models Expand Reach
Hybrid and decentralized trial models can bring research closer to patients by reducing travel demands, integrating local care providers, and using technology well. The flexibility of hybrid designs means that more people, especially those in rural or underserved areas, can take part without putting their lives on hold.
Decentralized models are especially effective for chronic or rare conditions where patients may be spread across large areas. They also support working adults, caregivers, and those with mobility challenges. By removing the expectation that patients must come to the research site, trials become more inclusive by design.
To make hybrid trials work, technology must be accessible and easy to use. Devices, apps, and platforms should be designed with patients in mind. Support must be available to help them use these tools effectively. When done right, this model turns the patient’s home into a study site that fits into their day-to-day life.
Designing Trials for Real Lives
When designing a study, researchers should consider more than just medical endpoints. We should consider how the study fits into real human lives. That means thinking about transportation, caregiving duties, work schedules, and the emotional burden of participation.
Patient advisory boards can be a valuable tool here. These groups give us insight into what patients actually experience, allowing us to adjust protocols and materials to reduce friction. Co-designing parts of the trial with patients leads to better results, fewer dropouts, and stronger data.
Trial sites can also be selected with access in mind. Using community clinics, mobile units, or pharmacies expands the footprint of research into spaces people already use. Even small adjustments like evening appointments or child-friendly waiting areas can make a big difference.
Ultimately, every decision in trial planning affects who shows up and who stays. By making those decisions with patient realities in mind, we help uncover those who have long been overlooked.
Reaching people who have been invisible to research is not only a moral responsibility but also a scientific one. Finding them is the first step; helping them understand a study well enough to decide is the second. See what trialport does for sponsors and CROs, or explore the live network.
About the author
Keith Berelowitz has spent more than twenty years watching clinical trials work on paper and struggle in real life. He has helped run studies, advises sponsors and CROs on how they engage with people, and chairs a UK research ethics committee, where consent forms and participant information sheets cross his desk every month. That vantage point led to one conclusion: most trial problems are not failures of science. They are failures of understanding at the moment a person decides.
He founded trialport, a clinical trial navigation and decision-support platform, on the view that finding a study is only the first step. A plain-language summary and the medifit™ + readifit™ self-reflection tools help people judge whether a trial fits their health and their life before they ever contact a site. Understanding comes first. Decisions follow.